RARA and breast cancer: By contrast, pharmacological inhibition of ERK signaling augmented RAR signaling-mediated gene expression, cell proliferation arrest, apoptosis and suppression of tumorigenicity in breast cancer cells (Figure 1, Figure 2, Figure 3, Figure 4 and Figure 5).